Abstract

BackgroundTo identify candidate key genes and pathways related to resting mast cells in meningioma and the underlying molecular mechanisms of meningioma.MethodsGene expression profiles of the used microarray datasets were obtained from the Gene Expression Omnibus (GEO) database. GO and KEGG pathway enrichments of DEGs were analyzed using the ClusterProfiler package in R. The protein-protein interaction network (PPI), and TF-miRNA- mRNA co-expression networks were constructed. Further, the difference in immune infiltration was investigated using the CIBERSORT algorithm.ResultsA total of 1499 DEGs were identified between tumor and normal controls. The analysis of the immune cell infiltration landscape showed that the probability of distribution of memory B cells, regulatory T cells (Tregs), and resting mast cells in tumor samples were significantly higher than those in the controls. Moreover, through WGCNA analysis, the module related to resting mast cells contained 158 DEGs, and KEGG pathway analysis revealed that the DEGs were dominant in the TNF signaling pathway, cytokine-cytokine receptor interaction, and IL-17 signaling pathway. Survival analysis of hub genes related to resting mast cells showed that the risk model was constructed based on 9 key genes. The TF-miRNA- mRNA co-regulation network, including MYC-miR-145-5p, TNFAIP3-miR-29c-3p, and TNFAIP3-hsa-miR-335-3p, were obtained. Further, 36 nodes and 197 interactions in the PPI network were identified.ConclusionThe results of this study revealed candidate key genes, miRNAs, and pathways related to resting mast cells involved in meningioma development, providing potential therapeutic targets for meningioma treatment.

Highlights

  • To identify candidate key genes and pathways related to resting mast cells in meningioma and the underlying molecular mechanisms of meningioma

  • Xie et al BMC Cancer (2021) 21:1209 to explore the molecular mechanism underlying the development of meningioma, as it will aid in disease treatment and patient prognosis improvement

  • We retrieved the meningioma-associated microarray data from Gene Expression Omnibus (GEO) databases in order to investigate tumor immune cell-related genes, transcription factors (TF), functional processes, and pathways that could be significantly correlated with meningioma development and overall patient survival

Read more

Summary

Introduction

To identify candidate key genes and pathways related to resting mast cells in meningioma and the underlying molecular mechanisms of meningioma. The tumor-related microenvironment consists of tumor immune cell types, density, and localization, and accumulating evidence has shown correlations between immune cell infiltration in different human tumors and clinical outcomes [11, 12]. Meningioma, an immune-sensitive malignant tumor, is infiltrated by numerous immune cells, including CD8 lymphocytes, macrophages and mast cells (MCs) [13]. In the last several decades, the importance of mast cells under several physiological and pathological conditions, has been described Their molecular mechanism in meningioma development remains unknown [14]. We retrieved the meningioma-associated microarray data from Gene Expression Omnibus (GEO) databases in order to investigate tumor immune cell-related genes, transcription factors (TF), functional processes, and pathways that could be significantly correlated with meningioma development and overall patient survival. Further analysis performed included tumorimmune cell related Differentially Expressed Gene (DEG) screening, Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis, survival analysis, TF-miRNA- mRNA and TF-miRNA- mRNA construction, Protein-Protein Interaction (PPI), and drug-gene construction

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call